The IMPACT Study is run by a dedicated team of collaborators who develop new and

improved approaches to preventing and treating patients with early phases of blood cancers.    

By pooling their knowledge and resources, they're working together to make rapid progress, and move therapies and treatments from the laboratory to doctors’ offices, where they can benefit patients.